The role of EMMPRIN/CD147 in regulating angiogenesis in patients with psoriatic arthritis.

Rahat, Michal A; Safieh, Mirna; Simanovich, Elina; Pasand, Eliran; Gazitt, Tal; Haddad, Amir; Elias, Muna; Zisman, Devy

Rahat, Michal A; Safieh, Mirna; Simanovich, Elina; Pasand, Eliran; Gazitt, Tal; Haddad, Amir; Elias, Muna; Zisman, Devy.

Afiliación

Rahat MA; Immunotherapy Laboratory, Carmel Medical Center, 3436212, Haifa, Israel. rahat_miki@clalit.org.il.
Safieh M; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 3109601, Haifa, Israel. rahat_miki@clalit.org.il.
Simanovich E; Immunotherapy Laboratory, Carmel Medical Center, 3436212, Haifa, Israel.
Pasand E; Rheumatology Unit Carmel Medical Center Haifa Israel, 3436212, Haifa, Israel.
Gazitt T; Immunotherapy Laboratory, Carmel Medical Center, 3436212, Haifa, Israel.
Haddad A; Immunotherapy Laboratory, Carmel Medical Center, 3436212, Haifa, Israel.
Elias M; Rheumatology Unit Carmel Medical Center Haifa Israel, 3436212, Haifa, Israel.
Zisman D; Rheumatology Unit Carmel Medical Center Haifa Israel, 3436212, Haifa, Israel.

Arthritis Res Ther ; 22(1): 240, 2020 10 14.

Article en En | MEDLINE | ID: mdl-33054815

Asunto(s)

Artritis Psoriásica; Artritis Reumatoide; Basigina; Células Endoteliales; Humanos; Neovascularización Patológica

Palabras clave

Angiogenesis; EMMPRIN/CD147; Psoriatic arthritis (PsA); Thrombospondin-1 (Tsp-1)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Artritis Psoriásica Límite: Humans Idioma: En Revista: Arthritis Res Ther Asunto de la revista: REUMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Israel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google